ArticleQRB discovery2025

'Druggability' of the Per-Arnt-Sim (PAS) domains of human PAS domain kinase, a therapeutic target for metabolic and liver disorders.

Shangze Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.